SCHEMBL20199799

SCHEMBL20199799

c1ccc(-n2c3ccccc3c3cc(-n4c5ccccc5c5cc6c(cc54)C4(c5ccccc5-c5ccccc54)c4cc5c7ccccc7n(-c7ccc8c(c7)c7ccccc7n8-c7ccccc7)c5cc4C64c5ccccc5-c5ccccc54)ccc32)cc1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 2/20 0.49
KDM4E B2RXH2 1/20 0.49
ATM Q13315 1/20 0.49
PTPN1 P18031 2/20 0.32
HDAC4 P56524 1/20 0.31
MAPK8 P45983 2/20 0.31
KMT2A Q03164 2/20 0.31
IL1R1 P14778 1/20 0.31
KDR P35968 1/20 0.30
MAPK9 P45984 1/20 0.30
MEN1 O00255 1/20 0.30
ALDH1A1 P00352 1/20 0.30
MAPT P10636 1/20 0.30
HTT P42858 1/20 0.30
DUSP3 P51452 1/20 0.30
PGR P06401 1/20 0.30
RAC2 P15153 1/20 0.30
RAC3 P60763 1/20 0.30
CDC42 P60953 1/20 0.30
RAC1 P63000 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20199452 0.99 KDM4E (0.47) L3MBTL1KDM4EATMPTPN1HDAC4
SCHEMBL20199480 0.95 L3MBTL1 (0.49) L3MBTL1KDM4EATMPTPN1HDAC4
SCHEMBL20199461 0.94 L3MBTL1 (0.55) L3MBTL1KDM4EATMPTPN1HDAC4
SCHEMBL16373500 0.93 KDM4E (0.47) L3MBTL1KDM4EATMPTPN1HDAC4
SCHEMBL15946311 0.93 KDM4E (0.47) L3MBTL1KDM4EATMPTPN1HDAC4
SCHEMBL15946331 0.93 KDM4E (0.47) L3MBTL1KDM4EATMPTPN1HDAC4
SCHEMBL14822433 0.93 KDM4E (0.47) L3MBTL1KDM4EATMPTPN1HDAC4
SCHEMBL14822252 0.93 KDM4E (0.47) L3MBTL1KDM4EATMPTPN1HDAC4
SCHEMBL20199793 0.93 KDM4E (0.47) L3MBTL1KDM4EATMPTPN1HDAC4
SCHEMBL20199437 0.93 L3MBTL1 (0.53) L3MBTL1KDM4EATMPTPN1HDAC4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11001752-B2 Double spiro organic compound and organic electronic element comprising same LG CHEM, LTD. (KR) 2021-05-11 US disclosed
US-20180148640-A1 DOUBLE SPIRO ORGANIC COMPOUND AND ORGANIC ELECTRONIC ELEMENT COMPRISING SAME LG CHEM, LTD. (KR) 2018-05-31 US disclosed
US-20180148640-A1 DOUBLE SPIRO ORGANIC COMPOUND AND ORGANIC ELECTRONIC ELEMENT COMPRISING SAME LG CHEM, LTD. (KR) 2018-05-31 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11001752-B2 Double spiro organic compound and organic electronic element comprising same DCX, TERT, TELO2 L3MBTL1 966/4885KDM4E 1392/4885ATM 849/4885
US-20180148640-A1 DOUBLE SPIRO ORGANIC COMPOUND AND ORGANIC ELECTRONIC ELEMENT COMPRISING SAME DCX, TERT, TELO2 L3MBTL1 966/4885KDM4E 1392/4885ATM 849/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.